Clopidogrel v placebo in addition to aspirin and standard fibrinolytic therapy for myocardial infarction (MI) with ST segment elevation*
| Outcomes at mean 3.5 days | Clopidogrel | Placebo | RRR (95% CI) | NNT (CI) |
|---|---|---|---|---|
| *Abbreviations defined in glossary; RRR, RRI, NNT, NNH, and CI calculated from data in article. | ||||
| †Composite primary outcome = an occluded infarct related artery, recurrent MI, or all cause mortality. | ||||
| Composite primary outcome† | 15% | 22% | 31% (20 to 40) | 15 (11 to 24) |
| Occluded infarct related artery | 12% | 18% | 64% (54 to 75) | 15 (11 to 24) |
| Recurrent myocardial infarction | 2.5% | 3.6% | 30% (−3 to 52) | Not significant |
| All cause mortality | 2.6% | 2.2% | 18% (−23 to 80) | Not significant |